122 related articles for article (PubMed ID: 10640842)
1. Clobetasol under hydrocolloid occlusion in psoriasis results in a complete block of proliferation and in a rebound of lesions following discontinuation.
Mommers JM; van Erp PE; van De Kerkhof PC
Dermatology; 1999; 199(4):323-7. PubMed ID: 10640842
[TBL] [Abstract][Full Text] [Related]
2. Clobetasol-17 propionate lotion under hydrocolloid dressing (Duoderm ET) once weekly versus unoccluded clobetasol-17-propionate ointment twice daily in psoriasis: an immunohistochemical study on remission and relapse.
van der Vleuten CJ; van Vlijmen-Willems IM; de Jong EM; van de Kerkhof PC
Arch Dermatol Res; 1999; 291(7-8):390-5. PubMed ID: 10482007
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric assessment of clearance and relapse characteristics in psoriasis vulgaris after treatment with weekly clobetasol lotion under hydrocolloid occlusion versus twice-daily clobetasol ointment.
Glade CP; van der Vleuten CJ; van Erp PE; van de Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 2002; 15(2):92-9. PubMed ID: 11867965
[TBL] [Abstract][Full Text] [Related]
4. Remission and relapse of chronic plaque psoriasis treated once a week with clobetasol propionate occluded with a hydrocolloid dressing versus twice daily treatment with clobetasol propionate alone.
Volden G; Kragballe K; Van De Kerkhof PC; Aberg K; White RJ
J Dermatolog Treat; 2001 Sep; 12(3):141-4. PubMed ID: 12243704
[TBL] [Abstract][Full Text] [Related]
5. Novel functional multiparameter flow cytometric assay to characterize proliferation in skin.
Mommers JM; Goossen JW; van De Kerkhof PC; van Erp PE
Cytometry; 2000 Feb; 42(1):43-9. PubMed ID: 10679742
[TBL] [Abstract][Full Text] [Related]
6. A clinical and flow cytometric model to study remission and relapse in psoriasis.
Glade CP; van Erp PE; Werner-Schlenzka H; van de Kerkhof PC
Acta Derm Venereol; 1998 May; 78(3):180-5. PubMed ID: 9602222
[TBL] [Abstract][Full Text] [Related]
7. The epidermal phenotype during initiation of the psoriatic lesion in the symptomless margin of relapsing psoriasis.
Castelijns FA; Gerritsen MJ; van Vlijmen-Willems IM; van Erp PE; van de Kerkhof PC
J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):901-9. PubMed ID: 10365920
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of calcipotriol ointment applied under hydrocolloid occlusion in psoriasis.
Castelijns FA; Gerritsen MJ; van Erp PE; van de Kerkhof PC
Dermatology; 2000; 200(1):25-30. PubMed ID: 10681609
[TBL] [Abstract][Full Text] [Related]
9. Changes in keratin 6 and keratin 10 (co-)expression in lesional and symptomless skin of spreading psoriasis.
Mommers JM; van Rossum MM; van Erp PE; van De Kerkhof PC
Dermatology; 2000; 201(1):15-20. PubMed ID: 10971053
[TBL] [Abstract][Full Text] [Related]
10. Ranking of the antipsoriatic effect of various topical corticosteroids applied under a hydrocolloid dressing--skin-thickness, blood-flow and colour measurements compared to clinical assessments.
Broby-Johansen U; Karlsmark T; Petersen LJ; Serup J
Clin Exp Dermatol; 1990 Sep; 15(5):343-8. PubMed ID: 2225536
[TBL] [Abstract][Full Text] [Related]
11. Monitoring hyperproliferative disorders in human skin: flow cytometry of changing cytokeratin expression.
Franssen ME; Boezeman JB; Van De Kerkhof PC; Van Erp PE
Cytometry B Clin Cytom; 2004 Jan; 57(1):32-9. PubMed ID: 14696061
[TBL] [Abstract][Full Text] [Related]
12. Use of a hydrocolloid dressing in combination with a topical steroid in plaque psoriasis.
Theeuwes M; Bright R
Cutis; 1996 Jan; 57(1):48-50. PubMed ID: 8620686
[TBL] [Abstract][Full Text] [Related]
13. VML 295 (LY-293111), a novel LTB4 antagonist, is not effective in the prevention of relapse in psoriasis.
Mommers JM; Van Rossum MM; Kooijmans-Otero ME; Parker GL; van de Kerkhof PC
Br J Dermatol; 2000 Feb; 142(2):259-66. PubMed ID: 10730758
[TBL] [Abstract][Full Text] [Related]
14. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of chronic skin diseases with clobetasol propionate and a hydrocolloid occlusive dressing.
Volden G
Acta Derm Venereol; 1992; 72(1):69-71. PubMed ID: 1350154
[TBL] [Abstract][Full Text] [Related]
16. Decrease in enkephalin levels in psoriatic lesions after calcipotriol and mometasone furoate treatment.
Nissen JB; Avrach WW; Hansen ES; Stengaard-Pedersen K; Kragballe K
Dermatology; 1999; 198(1):11-7. PubMed ID: 10026395
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of pulsed dye laser, pulsed dye laser + salicylic acid, and clobetasole propionate + salicylic acid on psoriatic plaques.
Ilknur T; Akarsu S; Aktan S; Ozkan S
Dermatol Surg; 2006 Jan; 32(1):49-55. PubMed ID: 16393598
[TBL] [Abstract][Full Text] [Related]
18. Antipsoriatic effect of local corticosteroids--O2-consumption and blood flow measurements compared to clinical parameters.
Broby-Johansen U; Kristensen JK
Clin Exp Dermatol; 1989 Mar; 14(2):137-40. PubMed ID: 2689017
[TBL] [Abstract][Full Text] [Related]
19. The immunohistochemical effect of a hydrocolloid occlusive dressing (DuoDERM E) in psoriasis vulgaris.
van Vlijmen-Willems IM; Chang A; Boezeman JB; van de Kerkhof PC
Dermatology; 1993; 187(4):257-62. PubMed ID: 7506086
[TBL] [Abstract][Full Text] [Related]
20. A hydrocolloid occlusive dressing plus triamcinolone acetonide cream is superior to clobetasol cream in palmo-plantar pustulosis.
Kragballe K; Larsen FG
Acta Derm Venereol; 1991; 71(6):540-2. PubMed ID: 1685841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
